MBX Stock Price | MBX Biosciences, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

MBX Biosciences, Inc. Common Stock • MBX

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About MBX Biosciences, Inc. Common Stock

Ticker

MBX

Trading on

NASDAQ

ISIN

US55287L1017

Industry

Biotechnology

Sector

Healthcare

CEO

Peter Kent Hawryluk MBA

Headquarters

11711 North Meridian Street, Carmel, IN, United States, 46032

Employees

Website

https://mbxbio.com

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Metrics

BasicAdvanced

Market cap

$1.15B

P/E ratio

3.33

EPS

$7.67

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-90.6M

Ex dividend date

Price & volume

Market cap

$1.15B

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

3.33

Forward P/E

PEG ratio

Trailing P/E

3.33

Price to sales

Price to book

3.42

Earnings

EPS

$7.67

EPS estimate (current quarter)

-$0.66

EPS estimate (next quarter)

-$0.66

EBITDA

$-90.6M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$26.47

52-week Low

$4.81

50-day moving average

$15.82

200-day moving average

$12.13

Short ratio

1.55

Short %

14.01%

Management effectiveness

ROE (TTM)

-24.43%

ROA (TTM)

-16.64%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

44.9M

Float

29.3M

Insiders %

2.73%

Institutions %

87.70%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 5 analysts.

Average price target

$61.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.47

-$0.59

19.85%

Q4 • 24Beat

-$0.71

-$0.77

7.92%

Q1 • 25Beat

-$0.58

-$0.76

24.00%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-19.4M

-∞%

Q2 • 25

$-21.6M

0.00%

Q3 • 25

NaN%

11.37%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$232M

$12.3M

5.31%

Q2 • 25

$400M

$12.5M

3.13%

Q3 • 25

72.80%

2.08%

-40.93%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-17.4M

$26M

$1.3M

$-18.1M

Q2 • 25

$-21.5M

$188M

$-21.9M

Q3 • 25

23.53%

14,064.71%

20.91%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a MBX Biosciences, Inc. Common Stock share?

MBX Biosciences, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does MBX Biosciences, Inc. Common Stock have?

MBX Biosciences, Inc. Common Stock currently has 44.9M shares.

Does MBX Biosciences, Inc. Common Stock pay dividends?

No, MBX Biosciences, Inc. Common Stock doesn't pay dividends.

What is MBX Biosciences, Inc. Common Stock 52 week high?

MBX Biosciences, Inc. Common Stock 52 week high is $26.47.

What is MBX Biosciences, Inc. Common Stock 52 week low?

MBX Biosciences, Inc. Common Stock 52 week low is $4.81.

What is the 200-day moving average of MBX Biosciences, Inc. Common Stock?

MBX Biosciences, Inc. Common Stock 200-day moving average is $12.13.

Who is MBX Biosciences, Inc. Common Stock CEO?

The CEO of MBX Biosciences, Inc. Common Stock is Peter Kent Hawryluk MBA.

How many employees MBX Biosciences, Inc. Common Stock has?

MBX Biosciences, Inc. Common Stock has 43 employees.

What is the market cap of MBX Biosciences, Inc. Common Stock?

The market cap of MBX Biosciences, Inc. Common Stock is $1.15B.

What is the P/E of MBX Biosciences, Inc. Common Stock?

The current P/E of MBX Biosciences, Inc. Common Stock is 3.33.

What is the EPS of MBX Biosciences, Inc. Common Stock?

The EPS of MBX Biosciences, Inc. Common Stock is $7.67.

What is the PEG Ratio of MBX Biosciences, Inc. Common Stock?

The PEG Ratio of MBX Biosciences, Inc. Common Stock is null.

What do analysts say about MBX Biosciences, Inc. Common Stock?

According to the analysts MBX Biosciences, Inc. Common Stock is considered a buy.